Dr. Vibha Jawa is Chief Scientific Officer at EpiVax, where she leads scientific strategy and innovation in immunogenicity and translational science. Previously, she held leadership roles at Bristol Myers Squibb, Merck, and Amgen, supporting biologics, vaccines, and cell and gene therapy development. With more than 20 years of industry experience, she has contributed to more than 20 IND, BLA, and MAA filings. Jawa has authored more than 75 peer-reviewed publications and serves in multiple leadership roles within AAPS and other scientific organizations. She was named an AAPS Fellow in 2022.
Vibha Jawa, PhD, discussed evolving approaches to preclinical development, animal use reduction, and immunogenicity assessment during an interview with BioPharm International at AAPS NBC 2026.
